Tampere University Hospital
Tampere, 33521, Finland
NCT Number: NCT06117111
This clinical investigation assesses the performance of PaMo patient monitor system (PaMo) and its wearable sensing devices that combines continuous IP, ECG and PPG in detecting developing respiratory depression episodes. PaMo patient monitor system consists of a wearable measurement unit worn on a patient, bedside mobile unit that receives the data from the wearable unit through Bluetooth Low Energy connection, visualises it, and can be relayed further to the central unit through WiFi network.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Tampere, 33521, Finland
Monitoring of voluntary subjects undergoing major surgery requiring postoperative intensive care treatment with PaMo patient monitoring device that includes continuous ECG, respiration and PPG monitoring.
The monitoring device is connected during anaesthesia preparation before induction of general anaesthesia and monitoring is continued throughout the surgery and in the intensive care unit (ICU) for total of 24 hours. For reference data, GE Carescape B850 patient monitors are used continuously for oxygen saturation, ECG and respiration signals. The data are collected from the reference patient monitor using a S/5 collect software and a study computer. In addition, to obtain a gold standard reference for SpO2 with blood gas analyzer arterial samples are taken every two hours during anesthesia and in the ICU concurrently with the routine checkups. During the surgery, an arterial cannula collects continuous blood pressure data and can be used for taking blood samples. The data collected with PaMo device and reference monitor are analyzed in Tampere University by researchers and used in device, software and algorithm development.
User experience information and usability feedback are collected at the end of the study from the medical staff with an interview form.
The study does not include a control group. All subjects are using the devices in similar way and the parameters collected from the same individual using two different methods are compared.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Comparison of the device to standard monitoring
Time frame: Continuous measurement 24 hours
Mean error an mean absolute error between the study device and standard monitor heart rae
Time frame: Continuous measurement 24 hours
Mean error and mean absolute error between the study monitor and standard monitor
Time frame: Continuous measurement 24 hours
Mean error and mean absolute error between the study monitor and standard monitor
Time frame: Continuous measurement 24 hours
usability of the evaluated patient monitoring solution for showing its usability, understandable user interface, suitability of the materials, unobtrusiveness, and fulfilment of related design input requirements. Questionnaire results
Time frame: Continuous measurement 24 hours
blood pressure Mean error and mean absolute error between the study monitor and standard monitor and algorithm development
Tampere University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07676227
Vital Sign Monitoring, Vital Signs
Tampere, Finland
View Trial DetailsNCT04725747
Vital Signs
Sioux Falls, South Dakota, United States
View Trial DetailsNCT07194122
Elderly (People Aged 65 or More), Vital Signs
Usansolo, Bizkaia, Spain
View Trial DetailsNCT07009275
Academic Acheivement, Animation
İzmit, Kocaeli, Turkey (Türkiye)
View Trial Details